Skip to Content

Zynex Inc ZYXI

Morningstar Rating
$11.91 −0.23 (1.89%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ZYXI is trading at a 7% discount.
Price
$11.93
Fair Value
$83.64
Uncertainty
High
1-Star Price
$45.52
5-Star Price
$2.92
Economic Moat
Byts
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZYXI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$12.14
Day Range
$11.8512.15
52-Week Range
$6.8814.75
Bid/Ask
$11.89 / $12.44
Market Cap
$380.28 Mil
Volume/Avg
157,974 / 222,173

Key Statistics

Price/Earnings (Normalized)
47.73
Price/Sales
2.41
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
9.67%

Company Profile

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Core
Total Number of Employees
1,101

Comparables

Valuation

Metric
ZYXI
OM
PEN
Price/Earnings (Normalized)
47.73148.39
Price/Book Value
8.770.957.25
Price/Sales
2.410.888.19
Price/Cash Flow
37.4149.15
Price/Earnings
ZYXI
OM
PEN

Financial Strength

Metric
ZYXI
OM
PEN
Quick Ratio
3.854.273.25
Current Ratio
4.745.266.06
Interest Coverage
12.50−13.3942.88
Quick Ratio
ZYXI
OM
PEN

Profitability

Metric
ZYXI
OM
PEN
Return on Assets (Normalized)
6.94%−39.03%5.67%
Return on Equity (Normalized)
15.57%−72.89%7.62%
Return on Invested Capital (Normalized)
8.83%−44.98%5.96%
Return on Assets
ZYXI
OM
PEN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Distribution Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MCK
McKesson CorpMnxtjhdPprpjp$69.3 Bil
COR
Cencora IncVxqmxjqpKczftfy$46.6 Bil
CAH
Cardinal Health IncTmwwtgjNwxryzv$25.6 Bil
SHTDY
Sinopharm Group Co Ltd ADRGcwvjw$8.0 Bil
SHPMF
Shanghai Pharmaceuticals Holding Co Ltd Class HLsmffgk$7.8 Bil
SHPMY
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class HTczrp$7.8 Bil
SHTDF
Sinopharm Group Co LtdXdxxhw$7.7 Bil
AMFPF
Amplifon SpA Az nom Post FrazionamentoVlsyj$7.6 Bil
MAHLY
Medipal Holdings Corp ADRMfxm$3.3 Bil
MEPDF
Medipal Holdings CorpQks$3.3 Bil

Sponsor Center